From Hell To Veins

July 14, 2010

Is The U.S. Government Planning To Mandate The Anthrax Vaccine?

My Commentary:
To call the anthrax vaccine, a vaccine, is like calling gasoline mouth wash. It only takes a little research to find out just how deadly an anthrax vaccine really is and it looks like the government awarded Rockville-based Emergent BioSolutions with a whopping $107 million contract to ready its anthrax vaccine for large-scale manufacture.

Yes, as with the absolute fraudulent H1N1 swine flu hoax where a bona fide hoax was craft between big pharma and big government on a global scale, this anthrax contract has all the same earmarks minus the announcement. They even brag in the article the ramp up is for a ‘global’ market.

What worries me as ‘mandatory insurance’ means ‘mandatory vaccines’ as some insurance companies are ALREADY quietly testing on the public. You maybe down the road ‘forced’ to take this vaccine via the new health care system and for ‘national security reasons’. Meaning the elite can make a buck while they cull the heard.

Emergent set to announce anthrax vaccine contract
Article:

By Marjorie Censer
Capital Business Staff Writer
Wednesday, July 14, 2010
Rockville-based Emergent BioSolutions is set to announce Wednesday that it has received a contract worth up to $107 million to ready its anthrax vaccine for large-scale manufacture.

Emergent said the award will help add up to $10 million in additional revenue — and pretax profit of up to $5 million — in the second half of 2010.

The Department of Health and Human Services’ Office of the Biomedical Advanced Research and Development Authority (BARDA) awarded the contract, which funds two years for a total of nearly $55 million and includes three additional, optional years.

According to Emergent, the contract will pay for the company to develop and obtain regulatory approval for large-scale manufacture of the vaccine, called BioThrax. BioThrax is the only vaccine licensed by the Food and Drug Administration to prevent anthrax infection.

“We expect that this investment by the government in increasing capacity will ultimately lead to large-scale procurement contracts,” said Daniel J. Abdun-Nabi, Emergent’s president and chief operating officer.

The company expects to begin making representative batches as early as the end of next year at its Lansing, Mich., facility and to submit the data to the FDA for regulatory approval of the plant and its processes as soon as 2013.

The award is based on an Emergent proposal that says the company can produce 26 million doses annually, a significant increase from the roughly 7 million to 9 million it generates today. But Abdun-Nabi said the Michigan facility can be further expanded to produce 50 million to 60 million doses annually.

Robin Robinson, director of BARDA, said the contract will mean an increased national supply of the vaccine.

“Our preparedness for anthrax will be much greater,” he said.

Beyond the U.S. government’s stockpile, Emergent said it anticipates potential sales abroad.

“We do see opportunities internationally. We are receiving calls,” Abdun-Nabi said. “There is increased awareness of the threat.

April 19, 2010

Vaccine Ready To Market Springboards Fear Mongering For Mild Virus.

Is this NOT what defines terrorism? Will vaccines hot off that vat such as this become mandatory?
Vaccine Near, So Fear Mongering Starts Over Another Mild Disease
by Heidi Stevenson
19 April 2010
Gaia health

Have you ever heard of respiratory syncytial virus (RSV)? In all likelihood, you haven’t, though you’e probably had it. You or your parents most likely called it a cold. Now though, there’s an RSV vaccine on the horizon, so the fear mongering is starting. Of course, to back up the fear, a study was done to give the impression that the disease is terrible. It was funded by vaccine promoters.

The Lancet has just published the study, which was financed by the Bill & Melinda Gates Foundation and the World Health Organization (WHO). The WHO is now being examined for its handling of the swine flu so-called pandemic. They stand accused of being in bed with pharmaceutical corporations to promote the use of vaccines. One of the Gates Foundation’s primary goals is to promote vaccines.

So, it should come as no surprise that the study’s results refer to RSV in terms that imply a severe problem. The article refers to its “global burden”. Because it’s a mild disease in normally healthy people, it focuses on developing nations. The study’s result was, of course, a foregone conclusion:

“The development of novel prevention and treatment strategies should be accelerated as a priority.”
Hint: That means focus on vaccinations, not on poverty, the real issue behind most deaths from minor illness.
The fear mongering has already started. BBC News has reported on HSV, describing it as “the single largest cause of lung infection in children”. That sounds so very terrible, but the reality isn’t necessarily so bad. After all, if you have a chesty cough, you have a lung infection. Do you automatically panic over it? Usually, such infections are referred to as the common cold.

RSV is a common disease at all ages. Unlike most viruses, which provide lifetime immunity after infection, only limited immunity occurs. It’s usually a mild disease, generally called a cold. In those with weakened immune systems, such as premature babies, it can be a serious disease, even leading to death. However, that happens in only a minuscule percentage of cases.

The Lancet focused on a single year, 2005. The authors reported that, worldwide, 66,000-199,000 children under age 5 died from RSV that year. This was misreported by BBC as simply 200,000 deaths in children under 5 worldwide, with the claim that it’s an annual figure, though the study was clear in pointing out that it referred only to a single year. Only 1% of these deaths occur in industrialized modern nations. The rest happen in the developing world, where malnutrition, lack of water, and poor sanitation are rampant. In other words, health is already compromised.

Rather than focusing on the most obvious issue relating to deaths from RSV, poor health from lack of the basic needs, the goal is to trot out a new vaccine. To have it accepted requires that people in the wealthier nations see it as a good thing—and that requires developing a hefty fear of the disease.

Big Pharma is brilliant at manipulating the media and creating false impressions through the use of phony grassroots groups and bribing researchers and doctors. They’ve already started to create an atmosphere of fear around the respiratory syncytial virus and its cold-like symptoms.

Once the vaccine is routinely administered to small children in industrialized nations—at enormous profits, of course—it can be pushed on impoverished people elsewhere. Of course, one must question who will bear the cost—but there can be little doubt. The WHO’s budget ultimately comes from the wealthier countries, and that means you and me.

Through all of this, consideration for safety will be nonexistent among the producers of the vaccine or the mainstream media or government agencies pushing it or mainstream medicine administering it. Those who express safety concerns will be marginalized, as always. Bit by painful bit, the truth will come out. But how long will it take? The experience of the last hundred years suggests that no amount of ill health or lives damaged will curtail Big Pharma from making its profits.

Create a free website or blog at WordPress.com.